Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome
- Teri J. Mauch
- , Michael R. Chladek
- , Spero Cataland
- , Shruti Chaturvedi
- , Bradley P. Dixon
- , Katherine Garlo
- , Christoph Gasteyger
- , Anuja Java
- , Jorge Leguizamo
- , Lucy Lloyd-Price
- , Tan P. Pham
- , Tara Symonds
- , Ioannis Tomazos
- , Yan Wang
Research output: Contribution to journal › Article › peer-review
15
Link opens in a new tab
Scopus
citations